York Medical

York Medical Inc., a Canadian company incorporated in 1994, develops cancer therapeutics. It partners with biotechnology and pharmaceutical companies, as well as with drug discovery organizations and academic institutes, to develop cancer applications of their novel agents and technologies. Products are in-licensed and taken through the regulatory and clinical research process generally to the completion of Phase II trials by YM’s team of clinical, regulatory, licensing and business development executives. YM’s product development plan anticipates out-licensing to major marketing and manufacturing companies at that stage.



York Medical continues to build a broad product portfolio of cancer therapeutics across a variety of technologies and indications. With three Phase II trials ongoing and five distinct cancer products expected to be in the clinic in 2001, YM has one of the broadest biotech oncology development programmes in North America.

Contact Details: 5045 Orbitor Drive, Bldg. 11, Suite 400 Mississauga Ontario L4W 4Y4 Canada Tel: 905 629 9761 Fax: 905 629 4959 Email: ir@yorkmedical.on.ca WWW: www.yorkmedical.on.ca/

Loading...

BioNews Results for York Medical:
Varitage Announces Executive And Senior Management	Pharma Live:  Oct 6 2008 12:53AM Matching: york medical
Latest Research Supports New AIDS Drug	WBAY Green Bay:  Oct 5 2008 8:32PM Matching: york medical
NIH Funding For New Epigenomics Initiative	Medical News Today:  Oct 5 2008 8:07AM Matching: york medical
Maraviroc Shows Efficacy Over 48 Weeks in Drug-Resistant Patients With R5 HIV	Doctors Guide:  Oct 5 2008 9:49PM Matching: york medical
Computer can help doctors spot breast cancer on mammograms	Prince George Citizen:  Oct 5 2008 3:23PM Matching: york medical
Promote your company here: BioNewsCast - Press Release Distribution	→View more York Medical news.

York Medical Patents:
US Patent No.	Title
7135497	Treating neural conditions resulting from spinal cord contusions and other causes
5616327	M-protein peptides of influenza virus as antiviral agents
5493009	Antiidiotypic monoclonal antibodies MK2-23 anti-melanomal antibody 763.74
5376534	Use of decreased 3-alpha-hydroxysteroid dehydrogenase activity in peripheral lymphocytes or other cells of patients with primary open angle glaucoma as a diagnostic indicator
5350766	Method for the prevention and/or palliation of the complications of diabetes using N-alpha orginine acetyl
→View more York Medical patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 234 times since April 2007, the link to the organisation's website has been followed 37 times

Recent Search Terms used to find this page: York Medical canadad | .

Search for more companies in Mississauga

Search for more companies in Ontario

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for York Medical